German biotech company MorphoSys buys US rival for $1.7B
Protein disguise could be new target for cancer immunotherapy
2 June 2021Partners play pivotal role in pregnant women’s alcohol use and babies’ development
2 June 2021German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
